Xcout Intel
Ferring Ventures competitors & alternatives
The 12 closest competitors and alternatives to Ferring Ventures among biotechnology companies — ranked by similarity to what Ferring Ventures actually does, not by market-cap band.
Subscribe to see Ferring Ventures’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Ferring Ventures
Ferring Ventures is a research company based in Kuopio, Finland, specializing in the translational field of cell therapy. The organization focuses on the discovery, establishment, and development of Advanced Therapy Medicinal Products (ATMPs) through Phase I and IIa clinical trials.
Ferring Ventures at a glance
Ferring Ventures is a biotechnology company headquartered in Switzerland. Xcout tracks 10 named people at Ferring Ventures, including Jean-Frédéric Paulsen (Managing Director).
Ferring Ventures leadership
- Jean-Frédéric PaulsenManaging Director
- Tuija KekarainenScientific Director -Site Head
- Joonas MalinenOperations Manager
- Katja SirviöCMC Manager
- Olga GurvichAnalytical Manager
- Sini SuomalainenProgram Manager
4 more named people on record for Ferring Ventures, with roles, board committees and tenure — see the full roster →
Top 12 Ferring Ventures competitors
Ranked by semantic similarity — how close each company is to Ferring Ventures by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotechnology company
Forward Pharma A/S is a clinical-stage biotechnology company driven by research and discovery, with headquarters located in Denmark.
Similar biotechnology company
Blue Cell Therapeutics is a biotechnology company founded in Copenhagen that focuses on revolutionizing the treatment of erectile dysfunction using specialized cell therapy.
Biotech
UnicoCell Biomed Co., Ltd., a Taiwanese enterprise, specializes in the research, development, and application of stem cell-based pharmaceuticals, advanced cell therapy techniques, and regenerative medical solutions. Their flagship product, ELIXCYTE, is presently undergoing Phase 2 clinical trials, targeting both osteoarthritis and chronic kidney disease. Beyond therapeutics, the company also offers UnicoVial, a specialized cryopreservation and drug containment system designed for cell therapy products, and provides a range of related testing services.
Biotech
TreeFrog Therapeutics is a French-based biotech company headquartered in Pessac, France. It aims to make iPS-derived cell therapies safer, more efficient, and more affordable to cure millions of patients.
Biotech
TILT Biotherapeutics is a Finnish biotechnology company developing tumor-targeted immunotherapies, including oncolytic adenoviruses designed to stimulate immune responses against solid tumors. Its therapies are intended for cancer patients and are developed through clinical and pharmaceutical partnerships.
Similar biotechnology company
Cellaïon is a privately held biotechnology company founded in March 2021 and headquartered in Mont-Saint-Guibert, Belgium. The firm operates in the field of cell therapy and liver regenerative medicine, developing advanced therapies aimed at repairing tissues and regenerating organs. Additionally, Cellaïon runs clinical trials for conditions such as urea cycle disorders, inborn errors of metabolism, acute hepatic failure, and hepatic cirrhosis.
Similar biotechnology company
cTRL Therapeutics is a biotechnology research company headquartered in Chicago, Illinois, United States, focused on innovative cellular science and therapeutics.
Biotech
Healios K.K., a Tokyo-based biopharmaceutical firm established in 2011, specializes in the discovery, development, manufacturing, and commercialization of advanced cell and regenerative medical therapies. The company operates across key markets including Japan, Europe, and the United States. Its robust pipeline features several cellular and tissue-based products, such as HLCR011 and HLCR012, which are induced pluripotent stem cell (iPSC)-derived regenerative medicines aimed at treating age-related macular degeneration. Another iPSC-based therapy, HLCL041, is being developed for metabolic liver disease. Furthermore, Healios is progressing HLCM051, a regenerative treatment designed for ischemic stroke and acute respiratory distress syndrome, alongside HLCN061 for solid tumor indications. The company also maintains a joint research partnership with Hyogo Medical University, focusing on eNK cell-based cancer immunotherapies to combat mesothelioma. Healios K.K. adopted its current name in September 2013, having previously operated under the name Retina Institute Japan, K.K.
Biotech
CO.DON is a biopharmaceutical company specializing in tissue engineering and the development and manufacturing of personalized cell therapies. The company provides regenerative treatments for joint cartilage defects to medical professionals and patients.
Similar biotechnology company
Phage Technologies advances safe, effective, and scalable phage technologies and services from Finland to combat global health threats such as antibiotic resistance.
Similar biotechnology company
Operating from its Tokyo headquarters, Cytori Cell Research Institute, Inc., established in 2004 (originally FRACTALE Corporation), specializes in the comprehensive research, development, production, and distribution of medical devices related to cell therapy throughout Japan. The company offers various cell therapy kits and continuously advances cellular treatment technologies through ongoing research and development. Its active development pipeline includes ECCI-50, designed for the treatment of male stress urinary incontinence and hepatic cirrhosis, and Cyt-006, formulated to prevent postoperative adhesion after primary rectal cancer surgery. Additionally, Cytori conducts extensive clinical trials and investigations into cell-based therapies for a wide array of conditions and applications, such as the repair of anterior cruciate ligaments and bones, burn scar remediation, chronic wound healing, critical limb ischemia, treatment of anal and Crohn's disease fistulas, and erectile dysfunction. Beyond its primary biotechnological focus, the company also participates in the real estate sector, encompassing investment, ownership, development, leasing, and management of properties and hotels, as well as providing real estate brokerage services.
Similar biotechnology company
Aurora Therapeutics is a biotechnology research company headquartered in Cambridge, Massachusetts. The firm focuses on advanced biomedical research and therapeutic development within the life sciences sector.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Ferring Ventures and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Ferring Venturesand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →